cerium has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, SI; Hyeon, T; Kang, T; Kim, D; Kim, YG; Kwon, HJ; Seo, K; Soh, M | 1 |
| Bharadwaj, S; Kaushik, AC; Kumar, S; Wei, DQ | 1 |
| Banerjee, T; Beach, J; Heckert, B; Naz, S; Pashchenko, O; Santra, S; Tummala, T | 1 |
1 review(s) available for cerium and Parkinson Disease
| Article | Year |
|---|---|
Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Blood-Brain Barrier; Cerium; Humans; Multiple Sclerosis; Nanomedicine; Nanoparticles; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease | 2017 |
2 other study(ies) available for cerium and Parkinson Disease
| Article | Year |
|---|---|
Ceria Nanoparticle Systems for Selective Scavenging of Mitochondrial, Intracellular, and Extracellular Reactive Oxygen Species in Parkinson's Disease.
Topics: Cell Line, Tumor; Cerium; Free Radical Scavengers; Humans; Hydrodynamics; Mitochondria; Nanoparticles; Parkinson Disease; Particle Size; Reactive Oxygen Species; Surface Properties | 2018 |
Nano-particle mediated inhibition of Parkinson's disease using computational biology approach.
Topics: alpha-Synuclein; Blood-Brain Barrier; Cerium; Humans; Molecular Dynamics Simulation; Nanoparticles; Parkinson Disease | 2018 |